Pooja budhiraja

Fue un honor compartir nuestra experiencia en trasplante de riñón y trasplante robótico de @mayoclinic en el 3er Congreso Internacional de Geriatría @medicasur @Blankmd22 @MCNguyenMD @MayoClinicNeph @SamiAlasfar @poojabudh

The Mayo MGRS Prediction Tool calculates the risk of finding monoclonal gammopathy of renal significance in a kidney biopsy in patients with monoclonal gammopathy - Kidney International @basmeomeo ⁦@fervenzafernan1⁩ ⁦@SethiRenalPath⁩ kidney-international.org/article/S0085-…

⭐ New in @Transpl_Int! Fusing clinical data with advanced CT-based body composition analysis, @poojabudh & team at @MayoClinic reveal more accurate prediction of Post-Transplant Diabetes Mellitus. Precision medicine for kidney recipients is here! @ESOTtransplant Read more ⬇️

Clinical and Radiological Fusion: A New Frontier in Predicting Post-Transplant Diabetes Mellitus @poojabudh @CarrieJadlowiec @HaniWadei @HariniChakkera @MayoClinicNeph @MayoTransplant frontierspartnerships.org/journals/trans… #Nephrology #Transplant @FrontiersIn

Performance of Glomerular Filtration Rate Estimating Equations in Kidney Transplant Recipients of Various Races: A Retrospective Cohort Study @poojabudh @wisit661 #MayoClinicKidney sciencedirect.com/science/articl…

NEWS 🚨 Iptacopan receives FDA approval for C3 glomerulopathy Treatment with iptacopant resulted in clinically meaningful proteinuria reduction, which was seen as early as 14 days and sustained at 12 months globenewswire.com/news-release/2…

frontiersin.org/journals/nephr… Higher donor eGFR was associated with lower risks of graft loss and patient death in the HLA-DR mismatch group but not the 0 HLA-DR mismatch group. These results emphasize the importance of considering both HLA-DR matching and donor kidney function,…

Join us!

The Outcomes of Adenovirus Infection in Kidney Transplant Recipients. #MayoClinicKidney @caschinstock @TambiJarmiMD @poojabudh onlinelibrary.wiley.com/doi/10.1111/ti…

10 transplants in 24 hours. Amazing demonstration of teamwork, optimal use of technology, and coordination of complex care. Proud of our team! newsnetwork.mayoclinic.org/discussion/10-…

frontiersin.org/journals/digit… “ Navigating pancreas transplant perceptions: assessing public sentiment and strategies using AI-driven analysis 📚” @OscarGarciaMD @poojabudh @CarrieJadlowiec @ShennenMao @napatlee1 @jingmiao2019 @Nadeenjk_MD @wisit661 #AI #Transplant

What a lovely end of year get together to celebrate 🎉 all the great achievements by our division! THANK YOU to all of our division members for all you do every day to help our patients get the best care possible and to keep advancing the science and education in #Nephrology!

Finishing off 2024 with 🔥🔥🔥 300th liver & 500th kidney transplant ✅✅✅ We cannot 🙏 our amazing team enough 💚💙💚 #MayoClinicArizona @MathurAmitK @aqel_bashar @Blankmd22 @peandrews60 @SamiAlasfar @poojabudh @MayoClinic

nam12.safelinks.protection.outlook.com/?url=https%3A%… Join me and Dr. Jadlowiec for our first Reddit #AMA on September 12! We will be answering any questions you may have around living kidney donation @CarrieJadlowiec @MayoTransplant @MayoClinicNepAZ

Addressing metabolic risk factors is critical in maintaining the health of the new transplant 🩺 So glad we are moving in this direction 🏃🏃‍♀️🏃‍♂️ @Blankmd22 @SamiAlasfar @poojabudh

pubmed.ncbi.nlm.nih.gov/39044330/ Excited to share our latest paper on integrating epidemiological data and conditional probabilities in kidney transplantation decision-making. Thanks Dr Jesse Schold, Dr Raymond Heilman, Dr Bruce Kaplan @MayoClinicNepAZ @MayoTransplant @CU_Transplant

No one is better than our PAs @paigiemo and Brandon at demonstration the mechanism of acting of IdES (Imlifidase). It is like watching the actual drug in action. @MayoClinicNepAZ @MayoTransplant @MayoClinic

ADPKD: Imaging diagnostic criteria #NKFClinicals 🇺🇸 #Nephpearls From @fouadchebib 👉 pubmed.ncbi.nlm.nih.gov/25074509/